SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001562180-21-002443
Filing Date
2021-03-26
Accepted
2021-03-26 16:14:49
Documents
2
Period of Report
2020-01-31

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 4/A  
1 PRIMARY DOCUMENT primarydocument.xml 4/A 7668
2 POA mheffernanpoa.txt EX-24 3292
  Complete submission text file 0001562180-21-002443.txt   12359
Mailing Address C/O CORNERSTONE THERAPEUTICS INC. 1255 CRESCENT GREEN DRIVE, SUITE 250 CARY NC 27518
Business Address
Heffernan Michael Thomas (Reporting) CIK: 0001448914 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-38080 | Film No.: 21777572

Mailing Address 215 CHURCH STREET NEW HAVEN CT 06510
Business Address 215 CHURCH STREET NEW HAVEN CT 06510 203-404-0410
Biohaven Pharmaceutical Holding Co Ltd. (Issuer) CIK: 0001689813 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations